These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sure cure: public policy on drug efficacy before 1962. Swann JP Publ Am Inst Hist Pharm; 1997; 16():223-61. PubMed ID: 11619897 [No Abstract] [Full Text] [Related]
23. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
24. [Local adverse reactions associated with parenteral administration of drugs]. Bjånes TK Tidsskr Nor Laegeforen; 2011 Mar; 131(5):472-4. PubMed ID: 21383802 [TBL] [Abstract][Full Text] [Related]
25. Two centuries of assessing drug risks. Avorn J N Engl J Med; 2012 Jul; 367(3):193-7. PubMed ID: 22808954 [No Abstract] [Full Text] [Related]
26. AIHP Kremers Award Address 2006. Pharmacovigilance and the missing denominator: the changing context of pharmaceutical risk mitigation. Daemmrich A Pharm Hist; 2007; 49(2):61-75. PubMed ID: 18368740 [No Abstract] [Full Text] [Related]
28. Drug shortages and patient safety: an overview of essential information for the infusion nurse. McLaughlin MM; Skoglund EW J Infus Nurs; 2015; 38(3):205-8. PubMed ID: 25871867 [TBL] [Abstract][Full Text] [Related]
29. Standards for particulate matter in all parenteral drug products. Jeffrey LP; Pinkus TF Am J Hosp Pharm; 1976 Sep; 33(9):879-80. PubMed ID: 984053 [No Abstract] [Full Text] [Related]
30. Response to the applicability of proposed large volume parenteral regulations to small volume parenteral drug products. Bull Parenter Drug Assoc; 1976; 30(6):265-79. PubMed ID: 1000103 [No Abstract] [Full Text] [Related]
31. Use and abuse of intravenous solutions. Vidt DG JAMA; 1975 May; 232(5):533-6. PubMed ID: 804572 [TBL] [Abstract][Full Text] [Related]
32. Guidelines for the administration of commonly used intravenous drugs. Rapp RP; Wermeling DP; Piecoro JJ Drug Intell Clin Pharm; 1984 Mar; 18(3):217-32. PubMed ID: 6697884 [No Abstract] [Full Text] [Related]
33. Effect of various factors on the amount of plasticizer in intravenous solutions packaged in flexible bags. Corley JH; Needham TE; Sumner ED; Mikeal R Am J Hosp Pharm; 1977 Mar; 34(3):259-64. PubMed ID: 16486 [No Abstract] [Full Text] [Related]
34. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related]
36. The Federal Food and Drug Administration in the United States: born and bred in crises. Taylor WJ Int J Clin Pharmacol; 1973 Apr; 7(2):156-62. PubMed ID: 4581340 [No Abstract] [Full Text] [Related]
37. Drugs and intravenous fluids. Breckenridge A; Woolfson AM Br Med J (Clin Res Ed); 1984 Sep; 289(6446):637-8. PubMed ID: 6434018 [No Abstract] [Full Text] [Related]
38. Recommendations to pharmacists for solving problems with large-volume parenterals. Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199 [No Abstract] [Full Text] [Related]
39. IV bolus: effective, but potentially hazardous (continuing education credit). Burman R; Berkowitz HS Crit Care Nurse; 1986; 6(1):22-8. PubMed ID: 3633789 [No Abstract] [Full Text] [Related]
40. Antimicrobial preservative use in parenteral products: past and present. Meyer BK; Ni A; Hu B; Shi L J Pharm Sci; 2007 Dec; 96(12):3155-67. PubMed ID: 17722087 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]